These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9160547)

  • 1. Growth hormone response to clonidine in the nervous pointer dog model of anxiety.
    Uhde TW; Malloy LC; Benson BB
    Anxiety; 1994; 1(2):45-9. PubMed ID: 9160547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine challenge in childhood anxiety disorder.
    Sallee FR; Richman H; Sethuraman G; Dougherty D; Sine L; Altman-Hamamdzic S
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):655-62. PubMed ID: 9628086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
    Coplan JD; Pine DS; Papp LA; Gorman JM
    Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
    [No Abstract]   [Full Text] [Related]  

  • 8. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions.
    Cameron OG
    Essent Psychopharmacol; 2006; 7(1):24-34. PubMed ID: 16989290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blunted growth hormone response to clonidine in panic disorder patients.
    Uhde TW; Vittone BJ; Siever LJ; Kaye WH; Post RM
    Biol Psychiatry; 1986 Sep; 21(11):1081-5. PubMed ID: 3741921
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
    Lovinger R; Holland J; Kaplan S; Grumbach M; Boryczka AT; Shackelford R; Salmon J; Reid IA; Ganong WF
    Neuroscience; 1976 Dec; 1(6):443-50. PubMed ID: 11370235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function.
    Cameron OG; Abelson JL; Young EA
    Biol Psychiatry; 2004 Dec; 56(11):875-83. PubMed ID: 15576065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone responses to growth hormone-releasing hormone and clonidine in dogs with Cushing's syndrome.
    Regnier A; Garnier F
    Res Vet Sci; 1995 Mar; 58(2):169-73. PubMed ID: 7761697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sleep deprivation on the growth hormone response to the alpha-3 adrenergic receptor agonist, clonidine, in normal subjects.
    Lal S; Thavundayil JX; Krishnan B; Nair NP; Schwartz G; Kiely ME; Guyda H
    J Neural Transm (Vienna); 1997; 104(2-3):291-8. PubMed ID: 9203090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone response to clonidine in panic disorder patients.
    Schittecatte M; Charles G; Depauw Y; Mesters P; Wilmotte J
    Psychiatry Res; 1988 Feb; 23(2):147-51. PubMed ID: 3363023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted growth hormone response to clonidine in Gilles de la Tourette syndrome.
    Müller N; Putz A; Klages U; Hofschuster E; Straube A; Ackenheil M
    Psychoneuroendocrinology; 1994; 19(4):335-41. PubMed ID: 8047638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    Biol Psychiatry; 1995 Aug; 38(3):201-3. PubMed ID: 7578668
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.